Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 11 Jul 2023

Identification of collateral sensitivity and evolutionary landscape of chemotherapy-induced drug resistance using cellular barcoding technology

in Pharmacology of Anti-Cancer Drugs

Nurseda Danisik
Kubra Celikbas Yilmaz
Ahmet Acar

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1178489

3,947 views
6 citations

Mini Review

Published on 07 Jul 2023

New insights into the therapeutic potentials of statins in cancer

in Pharmacology of Anti-Cancer Drugs

Chengyu Liu
Hong Chen
Bicheng Hu
Jiajian Shi
Yuchen Chen
Kun Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1188926

11,204 views
49 citations

Review

Published on 07 Jul 2023

Lysosomes, curcumin, and anti-tumor effects: how are they linked?

in Pharmacology of Anti-Cancer Drugs

Qian Shen
Xue Pan
Yi Li
Junchen Li
Chuanlong Zhang
Xiaochen Jiang
Fudong Liu
Bo Pang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1220983

5,581 views
9 citations

Review

Published on 06 Jul 2023

New hope for tumor immunotherapy: the macrophage-related “do not eat me” signaling pathway

in Pharmacology of Anti-Cancer Drugs

Han Deng
Guan Wang
Shengyan Zhao
Yiran Tao
Zhixiong Zhang
Jinliang Yang
Yi Lei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228962

10,340 views
19 citations

Systematic Review

Published on 06 Jul 2023

Comparison of the efficacy and safety of first-line treatments for of advanced EGFR mutation-positive non-small-cell lung cancer in Asian populations: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Wei Chen
Julian Miao
Ying Wang
Wenzhong Xing
Xiumei Xu
Rui Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1212313

8,520 views
7 citations

Mini Review

Published on 05 Jul 2023

Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib

in Pharmacology of Anti-Cancer Drugs

Zhimin Zhu
Qiongni Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1212986

7,536 views
13 citations

Original Research

Published on 04 Jul 2023

Bibliometric and visual analysis in the field of traditional Chinese medicine in cancer from 2002 to 2022

in Pharmacology of Anti-Cancer Drugs

Facheng Bai
Zhenguang Huang
Jun Luo
Yue Qiu
Shuwen Huang
Chenglong Huang
Taotao Liu
Hongliang Zhang
Dandan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164425

7,119 views
13 citations

Original Research

Published on 04 Jul 2023

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients

in Pharmacology of Anti-Cancer Drugs

Henrike Jacobi
Margherita Vieri
Marlena Bütow
Carolina Y. Namasu
Laura Flüter
Ivan G. Costa
Tiago Maié
Katharina Lindemann-Docter
Nicolas Chatain
Fabian Beier

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1212392

6,016 views
6 citations

Review

Published on 30 Jun 2023

Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment

in Pharmacology of Anti-Cancer Drugs

Weiping Li
Xia Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1211719

7,574 views
20 citations

Review

Published on 30 Jun 2023

Icariin as a potential anticancer agent: a review of its biological effects on various cancers

in Pharmacology of Anti-Cancer Drugs

Fang-Yuan Liu
Dan-Ni Ding
Yun-Rui Wang
Shao-Xuan Liu
Cheng Peng
Fang Shen
Xiao-Ya Zhu
Chan Li
Li-Ping Tang
Feng-Juan Han

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1216363

7,765 views
23 citations

Original Research

Published on 29 Jun 2023

Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration

in Pharmacology of Anti-Cancer Drugs

Li Gan
Qiyu Xiao
Yusong Zhou
Ying Fu
Mengjie Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1211675

2,864 views
5 citations

Original Research

Published on 29 Jun 2023

Novel structured ADAM17 small-molecule inhibitor represses ADAM17/Notch pathway activation and the NSCLC cells’ resistance to anti-tumour drugs

in Pharmacology of Anti-Cancer Drugs

Meng Chi
Yamin Jie
Ying Li
Duo Wang
Man Li
Dan Li
Mingyan E
Yongwu Li
Na Liu
Anxin Gu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189245

3,653 views
5 citations

Mini Review

Published on 29 Jun 2023

The effect of phytochemicals in N-methyl-N-nitro-N-nitroguanidine promoting the occurrence and development of gastric cancer

in Pharmacology of Anti-Cancer Drugs

Ling Lu
Bei Chen
XinYi Zhang
Yumeng Xu
Longtao Jin
Hui Qian
Zhao feng Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1203265

3,746 views
6 citations

Original Research

Published on 29 Jun 2023

Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Zili Hu
Zhenyun Yang
Yangxun Pan
Yizhen Fu
Jiongliang Wang
Zhongguo Zhou
Minshan Chen
Dandan Hu
Yaojun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1210835

2,696 views
4 citations

Mini Review

Published on 28 Jun 2023

Targeting the stimulator of interferon genes (STING) in breast cancer

in Pharmacology of Anti-Cancer Drugs

Ma Ying-Rui
Bai Bu-Fan
Liu Deng
Shi Rong
Zhou Qian-Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199152

5,906 views
17 citations

Case Report

Published on 28 Jun 2023

Case report: long-term sustained remission in a case of metastatic colon cancer with high microsatellite instability and KRAS exon 2 p.G12D mutation treated with fruquintinib after local radiotherapy: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Ruiqi Wang
Dan Cong
Yuansong Bai
Wenlong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1207369

3,980 views
2 citations